Skip to main content
Erschienen in: Journal of Gastrointestinal Cancer 2/2020

06.08.2019 | Review Article

Pancreatic Cancer in Iran: an Epidemiological Review

verfasst von: Fatemeh Hadavand Siri, Hamid Salehiniya

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Pancreatic cancer is the seventh cause of death in men in the world and also is one of the most common malignancies worldwide with poor prognosis. Due to the lack of epidemiological aspects of pancreatic cancer in Iran, this study aimed to investigate the epidemiological aspects of pancreatic cancer in Iran.

Methods

In February 2019, A search was conducted with the keywords “Pancreatic Neoplasm,” “Pancreas Neoplasms,” “Cancer of Pancreas,” “Pancreas Cancer,” “Pancreatic Cancer,” “Cancer of the Pancreas,” and “Iran” in their title or abstract and MeSH. The databases of Medline, Web of Science, Scopus, SID, IranMedex, and Google Scholar were searched. The title and abstract of the papers were reviewed, and articles that addressed the epidemiological aspects of pancreatic cancer were included; in total, 20 full papers were reviewed.

Results

According to studies, the incidence and mortality rate of pancreatic cancer is steadily increasing with age. Actually, men are more likely to develop this carcinoma than women. Smoking, aging, and lifestyle changes are the most important risk factors for pancreatic cancer in Iran. Due to the lack of initial symptoms or a specific marker for early diagnosis of pancreatic cancer, this cancer is detected lately and therefore low survival rate is observed.

Conclusion

Mortality and incidence of pancreatic cancer is increasing in Iran. Pancreatic cancer is more common in men than women. Based on the results of this study, pancreatic cancer depends largely on the lifestyle. Survival of pancreatic cancer is low in untreated patients.
Literatur
1.
Zurück zum Zitat Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.
2.
Zurück zum Zitat Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.PubMed Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.PubMed
3.
Zurück zum Zitat Wong MC, Jiang JY, Liang M, Fang Y, Yeung MS, Sung JJ. Global temporal patterns of pancreatic cancer and association with socioeconomic development. Sci Rep. 2017;7(1):3165.PubMedPubMedCentral Wong MC, Jiang JY, Liang M, Fang Y, Yeung MS, Sung JJ. Global temporal patterns of pancreatic cancer and association with socioeconomic development. Sci Rep. 2017;7(1):3165.PubMedPubMedCentral
4.
Zurück zum Zitat Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 2013;144(6):1252–61.PubMedPubMedCentral Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 2013;144(6):1252–61.PubMedPubMedCentral
5.
Zurück zum Zitat Veisani Y, Jenabi E, Khazaei S, Nematollahi S. Global incidence and mortality rates in pancreatic cancer and the association with the Human Development Index: decomposition approach. Public Health. 2018;156:87–91.PubMed Veisani Y, Jenabi E, Khazaei S, Nematollahi S. Global incidence and mortality rates in pancreatic cancer and the association with the Human Development Index: decomposition approach. Public Health. 2018;156:87–91.PubMed
6.
Zurück zum Zitat Wu W, He X, Yang L, Wang Q, Bian X, Ye J, et al. Rising trends in pancreatic cancer incidence and mortality in 2000–2014. Clin Epidemiol. 2018;10:789.PubMedPubMedCentral Wu W, He X, Yang L, Wang Q, Bian X, Ye J, et al. Rising trends in pancreatic cancer incidence and mortality in 2000–2014. Clin Epidemiol. 2018;10:789.PubMedPubMedCentral
8.
Zurück zum Zitat Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–88. Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–88.
9.
Zurück zum Zitat Ahmadloo N, Bidouei F, Omidvari S, Ansari M, Mosalaei A, Mohammadianpanah M. Pancreatic cancer in southern Iran. Iran Red Crescent Med J. 2010;12(6):624. Ahmadloo N, Bidouei F, Omidvari S, Ansari M, Mosalaei A, Mohammadianpanah M. Pancreatic cancer in southern Iran. Iran Red Crescent Med J. 2010;12(6):624.
10.
Zurück zum Zitat Hadizadeh M, Padashi M, Mohammad Alizadeh A, Zali MR. Clinical, laboratory biomarkers and imaging findings of pancreatic adenocarcinoma in Iran. Asian Pac J Cancer Prev. 2014;15(10):4349–52.PubMed Hadizadeh M, Padashi M, Mohammad Alizadeh A, Zali MR. Clinical, laboratory biomarkers and imaging findings of pancreatic adenocarcinoma in Iran. Asian Pac J Cancer Prev. 2014;15(10):4349–52.PubMed
11.
Zurück zum Zitat Pourhoseingholi MA, Fazeli Z, Ashtari S, Bavand-Pour FSF. Mortality trends of gastrointestinal cancers in Iranian population. Gastroenterol Hepatol Bed Bench. 2013;6(Suppl 1):S52–7.PubMedPubMedCentral Pourhoseingholi MA, Fazeli Z, Ashtari S, Bavand-Pour FSF. Mortality trends of gastrointestinal cancers in Iranian population. Gastroenterol Hepatol Bed Bench. 2013;6(Suppl 1):S52–7.PubMedPubMedCentral
12.
Zurück zum Zitat SALEHI F, AHMADI A, Ahmadi Soodejani SS, Shahini Shams Abadi M. The changing trend of mortality caused by gastrointestinal cancers in Iran during the years 2006-2010. Arq Gastroenterol. 2018;55(3):237–41.PubMed SALEHI F, AHMADI A, Ahmadi Soodejani SS, Shahini Shams Abadi M. The changing trend of mortality caused by gastrointestinal cancers in Iran during the years 2006-2010. Arq Gastroenterol. 2018;55(3):237–41.PubMed
13.
Zurück zum Zitat Zahir ST, Arjmand A, Kargar S, Neishaboury M. Incidence and trends of malignant and benign pancreatic lesions in Yazd, Iran between 2001 and 2011. Asian Pac J Cancer Prev. 2013;14:2631–5.PubMed Zahir ST, Arjmand A, Kargar S, Neishaboury M. Incidence and trends of malignant and benign pancreatic lesions in Yazd, Iran between 2001 and 2011. Asian Pac J Cancer Prev. 2013;14:2631–5.PubMed
14.
Zurück zum Zitat Masoompour SM, Yarmohammadi H, Rezaianzadeh A, Lankarani KB. Cancer incidence in southern Iran, 1998–2002: results of population-based cancer registry. Cancer Epidemiol. 2011;35(5):e42–7.PubMed Masoompour SM, Yarmohammadi H, Rezaianzadeh A, Lankarani KB. Cancer incidence in southern Iran, 1998–2002: results of population-based cancer registry. Cancer Epidemiol. 2011;35(5):e42–7.PubMed
15.
Zurück zum Zitat Momenyan S, Sadeghifar M, Sarvi F, Khodadost M, Mosavi-Jarrahi A, Ghaffari ME, et al. Relationship between urbanization and cancer incidence in Iran using quantile regression. Asian Pac J Cancer Prev. 2016;17(S3):113–7.PubMed Momenyan S, Sadeghifar M, Sarvi F, Khodadost M, Mosavi-Jarrahi A, Ghaffari ME, et al. Relationship between urbanization and cancer incidence in Iran using quantile regression. Asian Pac J Cancer Prev. 2016;17(S3):113–7.PubMed
16.
Zurück zum Zitat Anderson LN, Cotterchio M, Gallinger S. Lifestyle, dietary, and medical history factors associated with pancreatic cancer risk in Ontario, Canada. Cancer Causes Control. 2009;20(6):825–34.PubMedPubMedCentral Anderson LN, Cotterchio M, Gallinger S. Lifestyle, dietary, and medical history factors associated with pancreatic cancer risk in Ontario, Canada. Cancer Causes Control. 2009;20(6):825–34.PubMedPubMedCentral
17.
Zurück zum Zitat Hart AR, Kennedy H, Harvey I. Pancreatic cancer: a review of the evidence on causation. Clin Gastroenterol Hepatol. 2008;6(3):275–82.PubMed Hart AR, Kennedy H, Harvey I. Pancreatic cancer: a review of the evidence on causation. Clin Gastroenterol Hepatol. 2008;6(3):275–82.PubMed
18.
Zurück zum Zitat Pandol S, Gukovskaya A, Edderkoui M, Dawson D, Eibl G, Lugea A. Epidemiology, risk factors, and the promotion of pancreatic cancer: role of the stellate cell. J Gastroenterol Hepatol. 2012;27:127–34.PubMedPubMedCentral Pandol S, Gukovskaya A, Edderkoui M, Dawson D, Eibl G, Lugea A. Epidemiology, risk factors, and the promotion of pancreatic cancer: role of the stellate cell. J Gastroenterol Hepatol. 2012;27:127–34.PubMedPubMedCentral
19.
Zurück zum Zitat Stolzenberg-Solomon RZ, Adams K, Leitzmann M, Schairer C, Michaud DS, Hollenbeck A, et al. Adiposity, physical activity, and pancreatic cancer in the National Institutes of Health–AARP Diet and Health Cohort. Am J Epidemiol. 2008;167(5):586–97.PubMed Stolzenberg-Solomon RZ, Adams K, Leitzmann M, Schairer C, Michaud DS, Hollenbeck A, et al. Adiposity, physical activity, and pancreatic cancer in the National Institutes of Health–AARP Diet and Health Cohort. Am J Epidemiol. 2008;167(5):586–97.PubMed
20.
Zurück zum Zitat Grote V, Rohrmann S, Nieters A, Dossus L, Tjønneland A, Halkjaer J, et al. Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Diabetologia. 2011;54(12):3037–46.PubMed Grote V, Rohrmann S, Nieters A, Dossus L, Tjønneland A, Halkjaer J, et al. Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Diabetologia. 2011;54(12):3037–46.PubMed
21.
Zurück zum Zitat Silverman D, Schiffman M, Everhart J, Goldstein A, Lillemoe K, Swanson G, et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer. 1999;80(11):1830–7.PubMedPubMedCentral Silverman D, Schiffman M, Everhart J, Goldstein A, Lillemoe K, Swanson G, et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer. 1999;80(11):1830–7.PubMedPubMedCentral
22.
Zurück zum Zitat Chang M-C, Wong J-M, Chang Y-T. Screening and early detection of pancreatic cancer in high risk population. World J Gastroenterol: WJG. 2014;20(9):2358.PubMed Chang M-C, Wong J-M, Chang Y-T. Screening and early detection of pancreatic cancer in high risk population. World J Gastroenterol: WJG. 2014;20(9):2358.PubMed
23.
Zurück zum Zitat Bao Y, Stolzenberg-Solomon R, Jiao L, Silverman DT, Subar AF, Park Y, et al. Added sugar and sugar-sweetened foods and beverages and the risk of pancreatic cancer in the National Institutes of Health–AARP Diet and Health Study. Am J Clin Nutr. 2008;88(2):431–40.PubMedPubMedCentral Bao Y, Stolzenberg-Solomon R, Jiao L, Silverman DT, Subar AF, Park Y, et al. Added sugar and sugar-sweetened foods and beverages and the risk of pancreatic cancer in the National Institutes of Health–AARP Diet and Health Study. Am J Clin Nutr. 2008;88(2):431–40.PubMedPubMedCentral
24.
Zurück zum Zitat Bosetti C, Bravi F, Turati F, Edefonti V, Polesel J, Decarli A, et al. Nutrient-based dietary patterns and pancreatic cancer risk. Ann Epidemiol. 2013;23(3):124–8.PubMed Bosetti C, Bravi F, Turati F, Edefonti V, Polesel J, Decarli A, et al. Nutrient-based dietary patterns and pancreatic cancer risk. Ann Epidemiol. 2013;23(3):124–8.PubMed
25.
Zurück zum Zitat Zhang J, Dhakal IB, Gross MD, Lang NP, Kadlubar FF, Harnack LJ, et al. Physical activity, diet, and pancreatic cancer: a population-based, case-control study in Minnesota. Nutr Cancer. 2009;61(4):457–65.PubMedPubMedCentral Zhang J, Dhakal IB, Gross MD, Lang NP, Kadlubar FF, Harnack LJ, et al. Physical activity, diet, and pancreatic cancer: a population-based, case-control study in Minnesota. Nutr Cancer. 2009;61(4):457–65.PubMedPubMedCentral
27.
Zurück zum Zitat Fotouhi A, Khabazkhoob M, Hashemi H, Mohammad K. The prevalence of cigarette smoking in residents of Tehran. Arch Iran Med. 2009;12(4). Fotouhi A, Khabazkhoob M, Hashemi H, Mohammad K. The prevalence of cigarette smoking in residents of Tehran. Arch Iran Med. 2009;12(4).
28.
Zurück zum Zitat Pourshams A, Kazemi B, Kalantari S. A review of the etiology and biomarkers of pancreatic cancer, with emphasis on the role of diabetes: review article. Tehran Univ Med J. 2018;75(11):773–8. Pourshams A, Kazemi B, Kalantari S. A review of the etiology and biomarkers of pancreatic cancer, with emphasis on the role of diabetes: review article. Tehran Univ Med J. 2018;75(11):773–8.
29.
Zurück zum Zitat Ghorbani Z, Hekmatdoost A, Poustchi H, Pourshams A, Malekshah AF, Sharafkhah M, et al. The association between dietary carbohydrate intake and pancreatic cancer risk: a large prospective study. Govaresh. 2016;21(3):167–75. Ghorbani Z, Hekmatdoost A, Poustchi H, Pourshams A, Malekshah AF, Sharafkhah M, et al. The association between dietary carbohydrate intake and pancreatic cancer risk: a large prospective study. Govaresh. 2016;21(3):167–75.
30.
Zurück zum Zitat Ghorbani Z, Hekmatdoost A, Poustchi H, Pourshams A, Malekshah AF, Sharafkhah M, et al. Higher intake of dietary fiber, but not fruits or vegetables is associated with lower risk of pancreatic cancer: a large prospective study. Govaresh. 2017;22(1):17–27. Ghorbani Z, Hekmatdoost A, Poustchi H, Pourshams A, Malekshah AF, Sharafkhah M, et al. Higher intake of dietary fiber, but not fruits or vegetables is associated with lower risk of pancreatic cancer: a large prospective study. Govaresh. 2017;22(1):17–27.
31.
Zurück zum Zitat van Boeckel PG, Boshuizen HC, Siersema PD, Vrieling A, Kunst AE, Ye W, et al. No association between educational level and pancreatic cancer incidence in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol. 2010;34(6):696–701.PubMed van Boeckel PG, Boshuizen HC, Siersema PD, Vrieling A, Kunst AE, Ye W, et al. No association between educational level and pancreatic cancer incidence in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol. 2010;34(6):696–701.PubMed
32.
Zurück zum Zitat Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55(1):10–30.PubMed Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55(1):10–30.PubMed
33.
Zurück zum Zitat Pourhoseingholi MA, Pourhoseingholi A, Vahedi M, Ashtari S, Safaee A, Moghimi-Dehkordi B, et al. Decreased trend of pancreatic cancer mortality in Iran. Asian Pac J Cancer Prev. 2011;12(1):153–5.PubMed Pourhoseingholi MA, Pourhoseingholi A, Vahedi M, Ashtari S, Safaee A, Moghimi-Dehkordi B, et al. Decreased trend of pancreatic cancer mortality in Iran. Asian Pac J Cancer Prev. 2011;12(1):153–5.PubMed
34.
Zurück zum Zitat Coughlin SS, Calle EE, Patel AV, Thun MJ. Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control. 2000;11(10):915–23.PubMed Coughlin SS, Calle EE, Patel AV, Thun MJ. Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control. 2000;11(10):915–23.PubMed
35.
Zurück zum Zitat Fazeli Z, Fazeli Bavandpour F, Abdi A, Pour Hosaingholi M, Bastaminezhad. Trend analysis of pancreatic cancer mortality in Iran. J Ilam Univ Med Sci. 2013;20(4):239–45. Fazeli Z, Fazeli Bavandpour F, Abdi A, Pour Hosaingholi M, Bastaminezhad. Trend analysis of pancreatic cancer mortality in Iran. J Ilam Univ Med Sci. 2013;20(4):239–45.
36.
Zurück zum Zitat Baxter NN, Whitson BA, Tuttle TM. Trends in the treatment and outcome of pancreatic cancer in the United States. Ann Surg Oncol. 2007;14(4):1320–6.PubMed Baxter NN, Whitson BA, Tuttle TM. Trends in the treatment and outcome of pancreatic cancer in the United States. Ann Surg Oncol. 2007;14(4):1320–6.PubMed
37.
Zurück zum Zitat Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet. 2004;363(9414):1049–57.PubMed Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet. 2004;363(9414):1049–57.PubMed
38.
Zurück zum Zitat Zhang J, Dhakal I, Yan H, Phillips M, Kesteloot H. Trends in pancreatic cancer incidence in nine SEER Cancer Registries, 1973–2002. Ann Oncol. 2007;18(7):1268–79.PubMed Zhang J, Dhakal I, Yan H, Phillips M, Kesteloot H. Trends in pancreatic cancer incidence in nine SEER Cancer Registries, 1973–2002. Ann Oncol. 2007;18(7):1268–79.PubMed
39.
Zurück zum Zitat Bao Y, Hu F, Giovannucci E, Wolpin B, Stampfer M, Willett W, et al. Nut consumption and risk of pancreatic cancer in women. Br J Cancer. 2013;109(11):2911–6.PubMedPubMedCentral Bao Y, Hu F, Giovannucci E, Wolpin B, Stampfer M, Willett W, et al. Nut consumption and risk of pancreatic cancer in women. Br J Cancer. 2013;109(11):2911–6.PubMedPubMedCentral
40.
Zurück zum Zitat Cappellani A, Cavallaro A, Di Vita M, Zanghi A, Piccolo G, Lo Menzo E, et al. Diet and pancreatic cancer: many questions with few certainties. Eur Rev Med Pharmacol Sci. 2012;16(2):192–206.PubMed Cappellani A, Cavallaro A, Di Vita M, Zanghi A, Piccolo G, Lo Menzo E, et al. Diet and pancreatic cancer: many questions with few certainties. Eur Rev Med Pharmacol Sci. 2012;16(2):192–206.PubMed
41.
Zurück zum Zitat Rohrmann S, Linseisen J, Nöthlings U, Overvad K, Egeberg R, Tjønneland A, et al. Meat and fish consumption and risk of pancreatic cancer: results from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2013;132(3):617–24.PubMed Rohrmann S, Linseisen J, Nöthlings U, Overvad K, Egeberg R, Tjønneland A, et al. Meat and fish consumption and risk of pancreatic cancer: results from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2013;132(3):617–24.PubMed
42.
Zurück zum Zitat Taefi ANM, Ghorbani A, Fakheri H, Zahedi M, Semnani S, et al. Investigating the incidence of pancreatic and bile ducts in Iran: a population-based study. GOVARESH. 2011;13(4):6. Taefi ANM, Ghorbani A, Fakheri H, Zahedi M, Semnani S, et al. Investigating the incidence of pancreatic and bile ducts in Iran: a population-based study. GOVARESH. 2011;13(4):6.
43.
Zurück zum Zitat Jamali A, Kamgar M, Massarrat S, Sotoudeh M, Larijani B, Adler G, et al. Pancreatic cancer: state of the art and current situation in the Islamic Republic of Iran. Govaresh. 2009;14(3):189–97. Jamali A, Kamgar M, Massarrat S, Sotoudeh M, Larijani B, Adler G, et al. Pancreatic cancer: state of the art and current situation in the Islamic Republic of Iran. Govaresh. 2009;14(3):189–97.
44.
Zurück zum Zitat Taghavi A, Fazeli Z, Vahedi M, Baghestani AR, Zali MR, Pourhoseingholi MA. Pancreatic cancer mortality and misclassification--Bayesian analysis. Asian Pac J Cancer Prev. 2011;12(9):2271–4.PubMed Taghavi A, Fazeli Z, Vahedi M, Baghestani AR, Zali MR, Pourhoseingholi MA. Pancreatic cancer mortality and misclassification--Bayesian analysis. Asian Pac J Cancer Prev. 2011;12(9):2271–4.PubMed
45.
Zurück zum Zitat Amiresmaili M, Khanjani N, Moghadam MN, Isfahani P. Study of the avoidable mortality in Iran: Kerman Province. Iran Red Crescent Med J. 2013;15(4):345–9.PubMedPubMedCentral Amiresmaili M, Khanjani N, Moghadam MN, Isfahani P. Study of the avoidable mortality in Iran: Kerman Province. Iran Red Crescent Med J. 2013;15(4):345–9.PubMedPubMedCentral
46.
Zurück zum Zitat Moossavi S, Mohamadnejad M, Pourshams A, Poustchi H, Islami F, Sharafkhah M, et al. Opium use and risk of pancreatic cancer: a prospective cohort study. Cancer Epidemiol Prev Biomarkers. 2018;27(3):268–73. Moossavi S, Mohamadnejad M, Pourshams A, Poustchi H, Islami F, Sharafkhah M, et al. Opium use and risk of pancreatic cancer: a prospective cohort study. Cancer Epidemiol Prev Biomarkers. 2018;27(3):268–73.
47.
Zurück zum Zitat Shakeri R, Kamangar F, Mohamadnejad M, Tabrizi R, Zamani F, Mohamadkhani A, et al. Opium use, cigarette smoking, and alcohol consumption in relation to pancreatic cancer. Medicine. 2016;95(28):e3922.PubMedPubMedCentral Shakeri R, Kamangar F, Mohamadnejad M, Tabrizi R, Zamani F, Mohamadkhani A, et al. Opium use, cigarette smoking, and alcohol consumption in relation to pancreatic cancer. Medicine. 2016;95(28):e3922.PubMedPubMedCentral
48.
Zurück zum Zitat Farzin L, Moassesi ME, Sajadi F, Faghih MAA. Evaluation of trace elements in pancreatic cancer patients in Iran. Middle East J Cancer. 2013;4(2):79–86. Farzin L, Moassesi ME, Sajadi F, Faghih MAA. Evaluation of trace elements in pancreatic cancer patients in Iran. Middle East J Cancer. 2013;4(2):79–86.
49.
Zurück zum Zitat Ghorbani Z, Pourshams A, Fazeltabar MA, Sharafkhah M, Poustchi H, Hekmatdoost A (2016) Major dietary protein sources in relation to pancreatic cancer: a large prospective study. Ghorbani Z, Pourshams A, Fazeltabar MA, Sharafkhah M, Poustchi H, Hekmatdoost A (2016) Major dietary protein sources in relation to pancreatic cancer: a large prospective study.
Metadaten
Titel
Pancreatic Cancer in Iran: an Epidemiological Review
verfasst von
Fatemeh Hadavand Siri
Hamid Salehiniya
Publikationsdatum
06.08.2019
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Cancer / Ausgabe 2/2020
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-019-00279-w

Weitere Artikel der Ausgabe 2/2020

Journal of Gastrointestinal Cancer 2/2020 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.